Andrea Neilson

UBC Miller Mindell Research Fellow / GyneOncologist

[Eric Rios-Doria, MD @RiosDoriaMD]

Here in 📍Boston for #AACRec23!

What a privilege it is to be in the audience listening to one of my research mentors, Dr. @KemiDoll, give her talk “The Future of Endometrial Cancer Research: Progress and Purpose”

Her talk highlighted the disparities of Black women with #EndometrialCancer. There are so many reasons for why this may be, but one of the many striking slides in her presentation was the graph describing the overlapping vulnerability and underlying risk in care delay within endometrial cancer.

An excellent keynote to kick off this meeting!

@UWashOBGYN @UWMedicine @fredhutch @SwisherLiz @BarbaraAGoff @SGO_org @ECANAwomen @AdrienneEcana @gyncsm @AACR #gynoncology #disparities @SarahAckroydMD @VeeMuj

[Melissa M. Herbst-Kralovetz, PhD @HerbstKralovetz]

Check out our highly collaborative work on #endometrialcancer and #microbiome 🧫 work @AACR poster session #27 tonight presented by Dr. @ScientistNicole and tomorrow morning for her oral presentation! #AACRec23 #WomensHealth

[Mikayla Borthwick Bowen @MikaylaMDPhD]

Had a fantastic time at #AACRec23- great showcase on translational science in endometrial cancer, seeing my mentor @MelindaYatesPhD in person again, and connecting with some physician-scientist gynecologic oncologists that I have a career-crush on!! The future is bright 🩵🧬🔬

[Eric Rios-Doria, MD @RiosDoriaMD]

Special @SGO_org Board of Directors breakout session here at #AACRec23 😉

Dr. Bae-Jump & @levinemd (not pictured) have done a fantastic job as program chairs for this @AACR conference focused on #EndometrialCancer!

@@GYNCancer @AngelesSecord @amandanfader @karenluMD @ggardnermd @ShannonWestin @seoultrainmd @AnilSoodMD @FBackesMD @LPrescottMD @johnfarleyusma @LDuska @jubileebrown @BPothuri @DebbieRic23 #gyncancer #obgyntwitter #medtwitter #oncology #gyncsm

[Andrea Neilson @DrAndreaNeilson]

Amazing dual poster presentations at #AACRec23 by ⁦@DrAmyJamieson⁩ !! Outcomes in hyper methylated vs non-hypermethylated MMRd EC demonstrating worse outcomes and more immune cold tumours and ALSO sWGS is fast/effective in detecting CN alterations using FFPE. Congrats Amy!

[Dr. Marguerite Heyns @mheyns]

I spoke with @JenLeeCBC about the lack of comprehensive women’s health care in Lethbridge. This city deserves better. Glad to see that the CBC and others are paying attention. https://t.co/QxExtwwybq

[Jorge Hoegl. MD @oncohoegl]

One of my favorite topics since 2016 when I was starting my training as a Gyn Onc, don't stop listening to it, it's great!#IJGC #GynOnc #Podcast

@DrFHidalgo @ElizabethBelan @BasaloAnthony @sunangelae

[Laurence Bernard @laubernard]

Fantastic work by this international group led by Dr McAlpine.

*⃣ Adjuvant chemo and RT associated with ⬆️DSS for patients with p53abn EC, including non-serous ECs.
*⃣ Chemo ≠ improved outcomes in MMRd EC, even in stage III disease.

https://t.co/6IABISI94y

[Gynecologic Cancer Initiative @GCI_Cluster]

Beyond the Stories: Molecular Classification/ ProMisE is now out! 🎉 Watch to hear from patients Stephani and Margaret as well as Dr. Jessica McAlpine and Amy Jamieson, as they talk about the value of the ProMisE molecular classification system ⏩: https://t.co/ZRnvirZ3kf